Clinical Trials Browser

Phase 2 × capmatinib × Tumor-Agnostic × Clear all

NCT03693339 2018-10-03

Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping Mutation

Phase 2 Unknown

Neoplasms